These results highlight the potential direct effect of the BDNF-TrkB signaling pathway in the mechanism of action of antidepressants (Autry and Monteggia 2012) and evidenced that TrkB is a valuable target to treat depression. The gene discussed is NTRK2; the disease is depressive disorder.